Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk”

23,393 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23,393 results

Not applicableActive Not RecruitingNCT05027789
What this trial is testing

Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention

Who this might be right for
Memory DisordersCognitive Impairment
University of California, Davis 263
Testing effectiveness (Phase 2)UnknownNCT05005468
What this trial is testing

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Who this might be right for
NSCLC
Shanghai Chest Hospital 61
Not applicableUnknownNCT01273350
What this trial is testing

A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)

Who this might be right for
Carotid Stenosis
SPSI d.b.a Capital Cardiovascular Associates 154
Post-approval studies (Phase 4)Looking for participantsNCT04743518
What this trial is testing

Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Centre Hospitalier Universitaire, Amiens 100
Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Post-approval studies (Phase 4)Study completedNCT00555282
What this trial is testing

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)

Who this might be right for
BacteriaemiaCatheter Related Bloodstream Infection
B. Braun Melsungen AG 680
Not applicableStudy completedNCT02630082
What this trial is testing

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeLentivirus Infections+8 more
National Institute of Allergy and Infectious Diseases (NIAID) 29
Not applicableUnknownNCT02309996
What this trial is testing

SMART Supervisor Training Program to Prevent Work Disability

Who this might be right for
Work Disability Reduction and PreventionImproving Return-to-Work Outcomes
Lakehead University 350
Not applicableStudy completedNCT01771562
What this trial is testing

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 330
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Not applicableNot Yet RecruitingNCT06736873
What this trial is testing

Effect of Light Color on Stress, Anxiety, and Psychological Well-being During Nonstress Test in Pregnant Women at Risk

Who this might be right for
Pregnant WomenStressLight
Osmaniye Korkut Ata University 100
Not applicableStudy completedNCT07531173
What this trial is testing

Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events

Who this might be right for
Chronic Kidney Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 8,688
Not applicableStudy completedNCT01718769
What this trial is testing

Validation of the STAMP Screening Tool For Pediatric Nutritional Risk

Who this might be right for
Malnutrition
Meir Medical Center 60
Not applicableStudy completedNCT04506125
What this trial is testing

Liberal Versus Restrictive Transfusion Threshold in Oncologic surgerY

Who this might be right for
Oncologic ComplicationsAnemia
University Hospital, Brest 30
Early research (Phase 1)Looking for participantsNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Not applicableNot Yet RecruitingNCT06456840
What this trial is testing

Determination of Risk Factors of Shoulder Pathologies in Parkinson Disease

Who this might be right for
Parkinson DiseaseShoulder Pain
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 160
Not applicableActive Not RecruitingNCT06590350
What this trial is testing

Individualized NUTRItional RISK and Oriented Nutritional Support

Who this might be right for
Malnutrition
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT00551291
What this trial is testing

NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 10
Early research (Phase 1)Ended earlyNCT02595918
What this trial is testing

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 19
Load More Results